Drug Trial Radar · NCT06331026
A Bioequivalence Study of Two Different PEG-rhGH Preparations.
Last checked: Nov 20, 2026Latest source record: Nov 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
87
Actual
Start
Apr 9, 2024
Primary completion
Jul 15, 2024
Study completion Aug 28, 2024
Sponsor
- Lead sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate whether PEG-rhGH with new preparation is bioequivalent to PEG-rhGH with present preparation.
Conditions
- Pediatric Growth Hormone Deficiency (PGHD)
Interventions
PEG-rhGH with new preparation (T)Drug
A single subcutaneous injection of PEG-rhGH with new preparation
PEG-rhGH with present preparation (R)Drug
A single subcutaneous injection of PEG-rhGH with present preparation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics (Peak Plasma Concentration (Cmax) ) of PEG-rhGH with present and new preparationTime frame: 0 hours -192 hours post-administration
- Pharmacokinetics (Area under the concentration-time curve from time zero to time infinity (AUC0-inf)) of PEG-rhGH with present and new preparationTime frame: 0 hours -192 hours post-administration
- Pharmacokinetics (Area under the concentration-time curve from time zero to the time of the last quantifiable (AUC0- last )) of PEG-rhGH with present and new preparationTime frame: 0 hours -192hours post-administration
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Chengdu Xinhua Hospital
Chengdu, Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.